Reuben Shaw - Where Cures Begin – Episode 014
from Where Cures Begin - Salk Institute
Reuben Shaw is a professor and the director of the Salk Cancer Center. Fifteen years ago, he discovered that a gene frequently mutated in cancer (LKB1) regulates an enzyme named AMPK. Ever since, he has been studying the AMPK pathway to see if drugs originally designed to treat metabolic diseases could also work against cancer. On this episode of Where Cures Begin, Shaw talks about his initial discovery; what it's like running the Salk Cancer Center; and his continual drive to study the hardest-to-treat cancers.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Where Cures Begin - Salk Institute?
This episode is 15 minutes long.
When was this Where Cures Begin - Salk Institute episode published?
This episode was published on June 10, 2020.
Can I download this Where Cures Begin - Salk Institute episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.